Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

P, Connor; van Kammen M, Sánchez; AWA, Lensing; E, Chalmers; K, Kállay; K, Hege; P, Simioni; T, Biss; F, Bajolle; D, Bonnet; S, Grunt; R, Kumar; O, Lvova; R, Bhat; Damme A, Van; J, Palumbo; A, Santamaria; P, Saracco; J, Payne; S, Baird; K, Godder; V, Labarque; C, Male; I, Martinelli; Soto M, Morales; J, Motwani; S, Shah; HL, Hooimeijer; MH, Prins; D, Kubitza; WT, Smith; SD, Berkowitz; AF, Pap; M, Majumder; P, Monagle; JM, Coutinho

doi:10.1182/bloodadvances.2020003244

Public

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT).

Shared by NobleBlocks on Dec 1, 2020 • 12:00 AM UTC

Authors:

Connor P

Sánchez van Kammen M

Lensing AWA

Abstract

Anticoagulant treatment of pediatric cerebral venous thrombosis has not been evaluated in randomized trials. We evaluated the safety and efficacy of rivaroxaban and standard anticoagulants in the predefined subgroup of children with cerebral venous thrombosis (CVT) who participated in the EINSTEIN-J...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!